Some studies revealed that HO-1 targeting with either pegylated zinc protoporphyrin (PEG-ZnPP) or styrene maleicacid-micelle–encapsulated ZnPP (SMAZnPP) results in growth inhibition in cancer cells with subsequent increased sensitivity to radiotherapy and chemotherapy 22,38-40 . The gene discussed is HMOX1; the disease is cancer.